Home › Funds › Royce & Associates › CTSO
Royce & Associates position in CTSO
CYTOSORBENTS CORP · Health Care
Latest position (Q2 2022)349.00K sh
Reported value held$764.00K
Portfolio Weight0.01%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 196.00K | $1.59M | New |
| Q4 2021 | 251.00K | $1.05M | Add |
| Q1 2022 | 349.00K | $1.11M | Add |
| Q2 2022 | 349.00K | $764.00K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CTSO
- Vanguard Group 2.20M sh · $1.41M · Q4 2025
- BlackRock Inc 627.21K sh · $234.58K · Q2 2026
- Geode Capital Management 602.06K sh · $225.24K · Q2 2026
- UBS Group AG 131.02K sh · $49.00K · Q2 2026
- Northern Trust Corp 111.66K sh · $41.76K · Q2 2026
- Renaissance Technologies 100.02K sh · $37.41K · Q2 2026
- Morgan Stanley 91.34K sh · $34.16K · Q2 2026
- Bank of America Corp 38.69K sh · $14.47K · Q2 2026
- Goldman Sachs Group 15.34K sh · $5.74K · Q2 2026
- Citadel Advisors 14.40K sh · $5.39K · Q2 2026
- JPMorgan Chase & Co 372 sh · $142 · Q2 2026
- Wells Fargo & Co 250 sh · $94 · Q2 2026